Research Use Recombinant Protein Market worth $1.55 billion by 2031
The report "Research Use Recombinant Protein Market by Product (Cytokines, Growth Factors), Product Formulation (Lyophilized, Liquid), Species (Human, Mouse), Host Cell (Mammalian, Yeast), Application (Cell Culture), End User, Region - Global Forecast to 2031", is projected to grow from USD 1.11 billion in 2026 and to reach USD 1.55 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Browse 450 market data Tables and 50 Figures spread through 500 Pages and in-depth TOC on "Research Use Recombinant Protein Market by Product (Cytokines, Growth Factors), Product Formulation (Lyophilized, Liquid), Species (Human, Mouse), Host Cell (Mammalian, Yeast), Application (Cell Culture), End User, Region - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/research-use-recombinant-protein-market-156810846.html
The research use recombinant protein market is expanding steadily, supported by rising investment in life science research, broader adoption of cell-based assays, growth in proteomics and drug discovery, and increasing demand for standardized proteins in translational studies. Pharmaceutical and biotechnology companies, academic institutes, and CROs are using recombinant cytokines, growth factors, enzymes, chemokines, and antigens for cell culture, functional assays, target validation, biomarker research, and preclinical development. Demand is also shifting toward animal-free, carrier-free, highly pure, and low-endotoxin proteins that provide strong bioactivity and lot-to-lot consistency in sensitive research workflows. However, market growth is constrained by the high price of premium-grade proteins, stability and storage limitations, variability among suppliers, and technical difficulties in producing complex or properly folded proteins at consistent research quality.
“By product formulation, lyophilized recombinant proteins segment accounted for larger market share in 2025”
By product formulation, the market is segmented into lyophilized and liquid recombinant proteins. Lyophilized recombinant proteins accounted for the largest market share due to their longer shelf life, improved stability, convenient storage, and lower risk of activity loss during transportation. Researchers can reconstitute these proteins at the required concentrations for cell culture, functional assays, drug screening, biomarker studies, and protein interaction research. They are particularly suitable for laboratories managing extended research programs or maintaining protein inventories for repeated experiments. The broad availability of lyophilized cytokines, growth factors, enzymes, chemokines, receptors, and antigens, together with standardized reconstitution procedures and easier global distribution, further supports the segment’s leading position.
“By species, human segment accounted for largest market share in 2025”
By species, the market is segmented into human, mouse, rat, non-human primate, and other recombinant proteins. Human recombinant proteins accounted for the largest market share because of their extensive use in human disease modeling, therapeutic target validation, biomarker discovery, cell signaling studies, and preclinical drug research. These proteins provide biologically relevant interactions in human cell lines, primary cells, organoids, and tissue-based experimental models. Pharmaceutical and biotechnology companies, CROs, and academic institutions widely use human cytokines, growth factors, chemokines, enzymes, receptors, and antigens across oncology, immunology, neuroscience, infectious disease, and stem cell research.
“By region, North America accounted for largest market share in 2025”
In 2025, North America held the largest share of the research use recombinant protein market, supported by its well-established biopharmaceutical industry, extensive life science research infrastructure, and strong adoption of advanced experimental technologies. Recombinant proteins are widely used across the region in drug discovery, cell culture, protein interaction studies, biomarker research, disease modeling, and preclinical development. The presence of leading pharmaceutical and biotechnology companies, academic research institutions, CROs, and specialized protein suppliers creates sustained demand for high-purity and biologically active research proteins. Growing investment in oncology, immunology, neuroscience, regenerative medicine, and infectious disease research, together with increasing adoption of human cell-based assays and organoid models, further strengthens North America’s leading market position.
Some of the leading players in the market include Thermo Fisher Scientific Inc. (US), Bio-Techne (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity (US), BPS Bioscience, Inc. (US), Bio-Rad Laboratories, Inc. (US), Sartorius AG (Germany), Sino Biological, Inc. (China), and GenScript (China), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Research Use (RUO) Recombinant Protein Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
